Benitec Biopharma Ltd ADR
(BNTC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,592 | 97,857 | 103,646 | 78,345 | 67,905 |
| Receivables | 7 | 33 | 3 | 2 | 4 |
| Other current assets | 480 | 628 | 361 | 366 | 426 |
| TOTAL | $95,079 | $98,518 | $104,010 | $78,713 | $68,335 |
| Non-Current Assets | |||||
| PPE Net | 118 | 131 | 145 | 151 | 154 |
| Investments And Advances | 55 | 55 | 55 | 25 | 25 |
| Other Non-Current Assets | 775 | 888 | 999 | 179 | 260 |
| TOTAL | $948 | $1,074 | $1,199 | $355 | $439 |
| Total Assets | $96,027 | $99,592 | $105,209 | $79,068 | $68,774 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,148 | 1,022 | 6,254 | 2,415 | 3,847 |
| TOTAL | $2,025 | $1,802 | $7,026 | $3,089 | $4,553 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 38 | 41 |
| TOTAL | $403 | $495 | $613 | $38 | $41 |
| Total Liabilities | $2,428 | $2,297 | $7,639 | $3,127 | $4,594 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,862 | 26,250 | 25,600 | 23,451 | 23,216 |
| Common Shares | 2 | 2 | 2 | 2 | 1 |
| Retained earnings | -237,141 | -228,176 | -212,029 | -202,675 | -195,318 |
| Other shareholders' equity | -750 | -839 | -716 | -688 | -993 |
| TOTAL | $93,599 | $97,295 | $97,570 | $75,941 | $64,180 |
| Total Liabilities And Equity | $96,027 | $99,592 | $105,209 | $79,068 | $68,774 |